Status:
COMPLETED
Diagnostic Utility of Pleural Fluid MAGE Assay in Patients With Pleural Effusion From Primary Lung Cancer
Lead Sponsor:
Samsung Medical Center
Conditions:
Unilatral Pleural Effusion
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Melanoma antigen (MAGE) gene is known to be expressed in tumor cells, testis and placenta. The purpose of this prospective study was to investigate the sensitivity, specificity and accuracy of pleural...
Eligibility Criteria
Inclusion
- unilateral pleural effusion on chest radiography
Exclusion
- body temperature \> 38.3ºC and peripheral blood leukocytosis (\>12,000/μl)
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01179685
Start Date
January 1 2009
End Date
December 1 2010
Last Update
July 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710